Hematologic toxicities of sunitinib in patients with gastrointestinal stromal tumors: a systematic review and meta-analysis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-07-02

AUTHORS

Xuehui Jiang, Fangfang Xiong, Qun Fu, Hongwei Peng, Yan Jing, Kaisaner Rexiti, Xiaohua Wei, Song Tao

ABSTRACT

PurposeSunitinib offers a significant survival benefit to patients with imatinib-resistant gastrointestinal stromal tumors (GIST). However, the incidence and risk of sunitinib-induced hematologic toxicities in such a population are often overlooked and have not been well characterized. This meta-analysis was performed to assess the summary incidence and risk of hematologic toxicities secondary to sunitinib in patients with GIST.MethodsSearches were performed in PubMed, Embase, Cochrane Library, and Web of Science as well as ClinicalTrials.gov to identify relevant studies up to April 2022. Studies with adequate safety profile, including anemia, neutropenia, and thrombocytopenia, were included to calculate the pooled incidence, relative risk (RR), and corresponding 95% confidence intervals (CIs). This study was registered with PROSPERO under number CRD42022328202.ResultsA total of 2593 patients from 13 studies were included in the present meta-analysis. For patients with GIST assigned to sunitinib, the overall incidences of all-grade anemia, neutropenia, and thrombocytopenia were 26.2% (95% CI, 14.9–39.4%), 41.8% (95% CI, 29.0–55.1%), and 36.4% (95% CI, 22.8–51.1%), respectively. Regarding high-grade (grades 3 and 4) events, there were 4.7% (95% CI, 3.8–5.6%) for anemia, 9.3% (95% CI, 5.6–13.7%) for neutropenia and 5.0% (95% CI, 2.9–7.3%) for thrombocytopenia. Compared to placebo arms, sunitinib was related to an increased risk of high-grade neutropenia with an RR of 10.39 (95% CI, 1.53–70.72; p = 0.017).ConclusionsSunitinib carries a relatively high incidence of hematologic toxicities and a substantial increased risk of high-grade neutropenia in patients with GIST. Appropriate prevention and management seem to be inevitable. More... »

PAGES

1525-1534

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00384-022-04214-7

DOI

http://dx.doi.org/10.1007/s00384-022-04214-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1149183418

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35780257


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gastrointestinal Stromal Tumors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neutropenia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrroles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sunitinib", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombocytopenia", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China", 
          "id": "http://www.grid.ac/institutes/grid.412604.5", 
          "name": [
            "School of Pharmacy, Nanchang University, Nanchang, China", 
            "Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jiang", 
        "givenName": "Xuehui", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Pharmacy, Fujian Medical University, Fuzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.256112.3", 
          "name": [
            "School of Pharmacy, Fujian Medical University, Fuzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xiong", 
        "givenName": "Fangfang", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China", 
          "id": "http://www.grid.ac/institutes/grid.412604.5", 
          "name": [
            "School of Pharmacy, Nanchang University, Nanchang, China", 
            "Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fu", 
        "givenName": "Qun", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China", 
          "id": "http://www.grid.ac/institutes/grid.412604.5", 
          "name": [
            "Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Peng", 
        "givenName": "Hongwei", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Linyi Central Hospital, Linyi, China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Pharmacy, Linyi Central Hospital, Linyi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jing", 
        "givenName": "Yan", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China", 
          "id": "http://www.grid.ac/institutes/grid.412604.5", 
          "name": [
            "School of Pharmacy, Nanchang University, Nanchang, China", 
            "Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rexiti", 
        "givenName": "Kaisaner", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China", 
          "id": "http://www.grid.ac/institutes/grid.412604.5", 
          "name": [
            "Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wei", 
        "givenName": "Xiaohua", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China", 
          "id": "http://www.grid.ac/institutes/grid.412604.5", 
          "name": [
            "Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tao", 
        "givenName": "Song", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nature00821", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017873888", 
          "https://doi.org/10.1038/nature00821"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-009-9306-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030520095", 
          "https://doi.org/10.1007/s10637-009-9306-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41572-021-00254-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1136470602", 
          "https://doi.org/10.1038/s41572-021-00254-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-12-107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002590166", 
          "https://doi.org/10.1186/1471-2407-12-107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11864-022-00958-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1146682156", 
          "https://doi.org/10.1007/s11864-022-00958-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10147-012-0497-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043577201", 
          "https://doi.org/10.1007/s10147-012-0497-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40487-017-0052-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091919527", 
          "https://doi.org/10.1007/s40487-017-0052-4"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-07-02", 
    "datePublishedReg": "2022-07-02", 
    "description": "PurposeSunitinib offers a significant survival benefit to patients with imatinib-resistant gastrointestinal stromal tumors (GIST). However, the incidence and risk of sunitinib-induced hematologic toxicities in such a population are often overlooked and have not been well characterized. This meta-analysis was performed to assess the summary incidence and risk of hematologic toxicities secondary to sunitinib in patients with GIST.MethodsSearches were performed in PubMed, Embase, Cochrane Library, and Web of Science as well as ClinicalTrials.gov to identify relevant studies up to April 2022. Studies with adequate safety profile, including anemia, neutropenia, and thrombocytopenia, were included to calculate the pooled incidence, relative risk (RR), and corresponding 95% confidence intervals (CIs). This study was registered with PROSPERO under number CRD42022328202.ResultsA total of 2593 patients from 13 studies were included in the present meta-analysis. For patients with GIST assigned to sunitinib, the overall incidences of all-grade anemia, neutropenia, and thrombocytopenia were 26.2% (95% CI, 14.9\u201339.4%), 41.8% (95% CI, 29.0\u201355.1%), and 36.4% (95% CI, 22.8\u201351.1%), respectively. Regarding high-grade (grades 3 and 4) events, there were 4.7% (95% CI, 3.8\u20135.6%) for anemia, 9.3% (95% CI, 5.6\u201313.7%) for neutropenia and 5.0% (95% CI, 2.9\u20137.3%) for thrombocytopenia. Compared to placebo arms, sunitinib was related to an increased risk of high-grade neutropenia with an RR of 10.39 (95% CI, 1.53\u201370.72; p\u2009=\u20090.017).ConclusionsSunitinib carries a relatively high incidence of hematologic toxicities and a substantial increased risk of high-grade neutropenia in patients with GIST. Appropriate prevention and management seem to be inevitable.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00384-022-04214-7", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096381", 
        "issn": [
          "0179-1958", 
          "1432-1262"
        ], 
        "name": "International Journal of Colorectal Disease", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "37"
      }
    ], 
    "keywords": [
      "gastrointestinal stromal tumors", 
      "high-grade neutropenia", 
      "hematologic toxicity", 
      "relative risk", 
      "stromal tumors", 
      "imatinib-resistant gastrointestinal stromal tumors", 
      "significant survival benefit", 
      "adequate safety profile", 
      "confidence intervals", 
      "Web of Science", 
      "summary incidence", 
      "survival benefit", 
      "pooled incidence", 
      "grade anemia", 
      "overall incidence", 
      "safety profile", 
      "Cochrane Library", 
      "neutropenia", 
      "high incidence", 
      "patients", 
      "systematic review", 
      "thrombocytopenia", 
      "appropriate prevention", 
      "sunitinib", 
      "incidence", 
      "anemia", 
      "relevant studies", 
      "risk", 
      "tumors", 
      "toxicity", 
      "ConclusionsSunitinib", 
      "EMBASE", 
      "PROSPERO", 
      "high-grade events", 
      "PubMed", 
      "study", 
      "MethodsSearches", 
      "prevention", 
      "total", 
      "review", 
      "arm", 
      "population", 
      "interval", 
      "management", 
      "benefits", 
      "events", 
      "profile", 
      "Web", 
      "library", 
      "science"
    ], 
    "name": "Hematologic toxicities of sunitinib in patients with gastrointestinal stromal tumors: a systematic review and meta-analysis", 
    "pagination": "1525-1534", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1149183418"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00384-022-04214-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35780257"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00384-022-04214-7", 
      "https://app.dimensions.ai/details/publication/pub.1149183418"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:07", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_932.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00384-022-04214-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00384-022-04214-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00384-022-04214-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00384-022-04214-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00384-022-04214-7'


 

This table displays all metadata directly associated to this object as RDF triples.

219 TRIPLES      21 PREDICATES      90 URIs      75 LITERALS      15 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00384-022-04214-7 schema:about N16a258ced4334b02bac28354cc1238b6
2 N1cb80c56c0bc4f87b62639d9e81d666f
3 N6fbe7e351ea54d5cb999cdbcf987079b
4 N813476d5d74f43b0bdb5efc62f2a0fb9
5 N860ba3d1b0714bde8b75300acc777341
6 Nb2a42aefea2143e5bb7e1925eab08573
7 Nde713c52ba8b430e985850138d88cb8d
8 Nf7ccdd87a8754993a9da15a9bd9979c1
9 anzsrc-for:11
10 anzsrc-for:1117
11 schema:author N4edffcf201b847698da831a30d7a2891
12 schema:citation sg:pub.10.1007/s10147-012-0497-2
13 sg:pub.10.1007/s10637-009-9306-9
14 sg:pub.10.1007/s11864-022-00958-0
15 sg:pub.10.1007/s40487-017-0052-4
16 sg:pub.10.1038/nature00821
17 sg:pub.10.1038/s41572-021-00254-5
18 sg:pub.10.1186/1471-2407-12-107
19 schema:datePublished 2022-07-02
20 schema:datePublishedReg 2022-07-02
21 schema:description PurposeSunitinib offers a significant survival benefit to patients with imatinib-resistant gastrointestinal stromal tumors (GIST). However, the incidence and risk of sunitinib-induced hematologic toxicities in such a population are often overlooked and have not been well characterized. This meta-analysis was performed to assess the summary incidence and risk of hematologic toxicities secondary to sunitinib in patients with GIST.MethodsSearches were performed in PubMed, Embase, Cochrane Library, and Web of Science as well as ClinicalTrials.gov to identify relevant studies up to April 2022. Studies with adequate safety profile, including anemia, neutropenia, and thrombocytopenia, were included to calculate the pooled incidence, relative risk (RR), and corresponding 95% confidence intervals (CIs). This study was registered with PROSPERO under number CRD42022328202.ResultsA total of 2593 patients from 13 studies were included in the present meta-analysis. For patients with GIST assigned to sunitinib, the overall incidences of all-grade anemia, neutropenia, and thrombocytopenia were 26.2% (95% CI, 14.9–39.4%), 41.8% (95% CI, 29.0–55.1%), and 36.4% (95% CI, 22.8–51.1%), respectively. Regarding high-grade (grades 3 and 4) events, there were 4.7% (95% CI, 3.8–5.6%) for anemia, 9.3% (95% CI, 5.6–13.7%) for neutropenia and 5.0% (95% CI, 2.9–7.3%) for thrombocytopenia. Compared to placebo arms, sunitinib was related to an increased risk of high-grade neutropenia with an RR of 10.39 (95% CI, 1.53–70.72; p = 0.017).ConclusionsSunitinib carries a relatively high incidence of hematologic toxicities and a substantial increased risk of high-grade neutropenia in patients with GIST. Appropriate prevention and management seem to be inevitable.
22 schema:genre article
23 schema:isAccessibleForFree false
24 schema:isPartOf N26e7199be67e472eb8b22df01c89a828
25 Nd4fbdf7555ad4fe2b39002b246e475b7
26 sg:journal.1096381
27 schema:keywords Cochrane Library
28 ConclusionsSunitinib
29 EMBASE
30 MethodsSearches
31 PROSPERO
32 PubMed
33 Web
34 Web of Science
35 adequate safety profile
36 anemia
37 appropriate prevention
38 arm
39 benefits
40 confidence intervals
41 events
42 gastrointestinal stromal tumors
43 grade anemia
44 hematologic toxicity
45 high incidence
46 high-grade events
47 high-grade neutropenia
48 imatinib-resistant gastrointestinal stromal tumors
49 incidence
50 interval
51 library
52 management
53 neutropenia
54 overall incidence
55 patients
56 pooled incidence
57 population
58 prevention
59 profile
60 relative risk
61 relevant studies
62 review
63 risk
64 safety profile
65 science
66 significant survival benefit
67 stromal tumors
68 study
69 summary incidence
70 sunitinib
71 survival benefit
72 systematic review
73 thrombocytopenia
74 total
75 toxicity
76 tumors
77 schema:name Hematologic toxicities of sunitinib in patients with gastrointestinal stromal tumors: a systematic review and meta-analysis
78 schema:pagination 1525-1534
79 schema:productId N038a9b39d5134c068942c6eab9e37e7d
80 N100788dccc8348abb1b26e366ecbd970
81 Nf204ae9bd66c4a16a9013fc7581ba404
82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1149183418
83 https://doi.org/10.1007/s00384-022-04214-7
84 schema:sdDatePublished 2022-09-02T16:07
85 schema:sdLicense https://scigraph.springernature.com/explorer/license/
86 schema:sdPublisher Nce798bb63cc344f3be1d65c4fc192417
87 schema:url https://doi.org/10.1007/s00384-022-04214-7
88 sgo:license sg:explorer/license/
89 sgo:sdDataset articles
90 rdf:type schema:ScholarlyArticle
91 N038a9b39d5134c068942c6eab9e37e7d schema:name dimensions_id
92 schema:value pub.1149183418
93 rdf:type schema:PropertyValue
94 N06379593f72b485f8b0bfd248b4ebd58 rdf:first N151d12b019fb4f0797e5f5c60d51ecf0
95 rdf:rest N1aeb45ec276b4e8daf64ef375ff8a638
96 N100788dccc8348abb1b26e366ecbd970 schema:name doi
97 schema:value 10.1007/s00384-022-04214-7
98 rdf:type schema:PropertyValue
99 N151d12b019fb4f0797e5f5c60d51ecf0 schema:affiliation grid-institutes:grid.412604.5
100 schema:familyName Rexiti
101 schema:givenName Kaisaner
102 rdf:type schema:Person
103 N16a258ced4334b02bac28354cc1238b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Antineoplastic Agents
105 rdf:type schema:DefinedTerm
106 N1aeb45ec276b4e8daf64ef375ff8a638 rdf:first N8c34f7667e594aa1b9bda31bbd11b2dc
107 rdf:rest N34354f4568854045b2c312c9b441121f
108 N1cb80c56c0bc4f87b62639d9e81d666f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Gastrointestinal Stromal Tumors
110 rdf:type schema:DefinedTerm
111 N20ce9e87cfee4ca98735f5b7965e377c schema:affiliation grid-institutes:grid.412604.5
112 schema:familyName Fu
113 schema:givenName Qun
114 rdf:type schema:Person
115 N26e7199be67e472eb8b22df01c89a828 schema:volumeNumber 37
116 rdf:type schema:PublicationVolume
117 N34354f4568854045b2c312c9b441121f rdf:first Nf05ad78b949245cbbb895c8df18df78b
118 rdf:rest rdf:nil
119 N3870e5ff1b6e4f16a2c1b61c40dd1208 schema:affiliation grid-institutes:grid.412604.5
120 schema:familyName Jiang
121 schema:givenName Xuehui
122 rdf:type schema:Person
123 N4452c1717cbc44939a1b0b3744886725 schema:affiliation grid-institutes:None
124 schema:familyName Jing
125 schema:givenName Yan
126 rdf:type schema:Person
127 N4edffcf201b847698da831a30d7a2891 rdf:first N3870e5ff1b6e4f16a2c1b61c40dd1208
128 rdf:rest Ne7147102aab54e48a263952e95f8f51f
129 N6fbe7e351ea54d5cb999cdbcf987079b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Pyrroles
131 rdf:type schema:DefinedTerm
132 N77e5b90ad02c465596a4544c03b0ee79 schema:affiliation grid-institutes:grid.256112.3
133 schema:familyName Xiong
134 schema:givenName Fangfang
135 rdf:type schema:Person
136 N813476d5d74f43b0bdb5efc62f2a0fb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Neutropenia
138 rdf:type schema:DefinedTerm
139 N860ba3d1b0714bde8b75300acc777341 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Anemia
141 rdf:type schema:DefinedTerm
142 N8c34f7667e594aa1b9bda31bbd11b2dc schema:affiliation grid-institutes:grid.412604.5
143 schema:familyName Wei
144 schema:givenName Xiaohua
145 rdf:type schema:Person
146 N8d40892f48d943a88ffbffc7ab15ed41 schema:affiliation grid-institutes:grid.412604.5
147 schema:familyName Peng
148 schema:givenName Hongwei
149 rdf:type schema:Person
150 Na052143fb0c948ba936378a3f9bf1a0a rdf:first N8d40892f48d943a88ffbffc7ab15ed41
151 rdf:rest Nf245359ddac24ab284307756aab7d84a
152 Nb128d25564a649b99294a64afa84358b rdf:first N20ce9e87cfee4ca98735f5b7965e377c
153 rdf:rest Na052143fb0c948ba936378a3f9bf1a0a
154 Nb2a42aefea2143e5bb7e1925eab08573 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Humans
156 rdf:type schema:DefinedTerm
157 Nce798bb63cc344f3be1d65c4fc192417 schema:name Springer Nature - SN SciGraph project
158 rdf:type schema:Organization
159 Nd4fbdf7555ad4fe2b39002b246e475b7 schema:issueNumber 7
160 rdf:type schema:PublicationIssue
161 Nde713c52ba8b430e985850138d88cb8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Sunitinib
163 rdf:type schema:DefinedTerm
164 Ne7147102aab54e48a263952e95f8f51f rdf:first N77e5b90ad02c465596a4544c03b0ee79
165 rdf:rest Nb128d25564a649b99294a64afa84358b
166 Nf05ad78b949245cbbb895c8df18df78b schema:affiliation grid-institutes:grid.412604.5
167 schema:familyName Tao
168 schema:givenName Song
169 rdf:type schema:Person
170 Nf204ae9bd66c4a16a9013fc7581ba404 schema:name pubmed_id
171 schema:value 35780257
172 rdf:type schema:PropertyValue
173 Nf245359ddac24ab284307756aab7d84a rdf:first N4452c1717cbc44939a1b0b3744886725
174 rdf:rest N06379593f72b485f8b0bfd248b4ebd58
175 Nf7ccdd87a8754993a9da15a9bd9979c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Thrombocytopenia
177 rdf:type schema:DefinedTerm
178 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
179 schema:name Medical and Health Sciences
180 rdf:type schema:DefinedTerm
181 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
182 schema:name Public Health and Health Services
183 rdf:type schema:DefinedTerm
184 sg:journal.1096381 schema:issn 0179-1958
185 1432-1262
186 schema:name International Journal of Colorectal Disease
187 schema:publisher Springer Nature
188 rdf:type schema:Periodical
189 sg:pub.10.1007/s10147-012-0497-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043577201
190 https://doi.org/10.1007/s10147-012-0497-2
191 rdf:type schema:CreativeWork
192 sg:pub.10.1007/s10637-009-9306-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030520095
193 https://doi.org/10.1007/s10637-009-9306-9
194 rdf:type schema:CreativeWork
195 sg:pub.10.1007/s11864-022-00958-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1146682156
196 https://doi.org/10.1007/s11864-022-00958-0
197 rdf:type schema:CreativeWork
198 sg:pub.10.1007/s40487-017-0052-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091919527
199 https://doi.org/10.1007/s40487-017-0052-4
200 rdf:type schema:CreativeWork
201 sg:pub.10.1038/nature00821 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017873888
202 https://doi.org/10.1038/nature00821
203 rdf:type schema:CreativeWork
204 sg:pub.10.1038/s41572-021-00254-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1136470602
205 https://doi.org/10.1038/s41572-021-00254-5
206 rdf:type schema:CreativeWork
207 sg:pub.10.1186/1471-2407-12-107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002590166
208 https://doi.org/10.1186/1471-2407-12-107
209 rdf:type schema:CreativeWork
210 grid-institutes:None schema:alternateName Department of Pharmacy, Linyi Central Hospital, Linyi, China
211 schema:name Department of Pharmacy, Linyi Central Hospital, Linyi, China
212 rdf:type schema:Organization
213 grid-institutes:grid.256112.3 schema:alternateName School of Pharmacy, Fujian Medical University, Fuzhou, China
214 schema:name School of Pharmacy, Fujian Medical University, Fuzhou, China
215 rdf:type schema:Organization
216 grid-institutes:grid.412604.5 schema:alternateName Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China
217 schema:name Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China
218 School of Pharmacy, Nanchang University, Nanchang, China
219 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...